| Peer-Reviewed

Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient

Received: 5 February 2019     Accepted: 11 March 2019     Published: 16 October 2019
Views:       Downloads:
Abstract

Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide and causes anal cancer. The incidence of HPV infections in renal transplant recipients is 17% to 45%. Using immunosuppression treatment has been associated with significantly lower risks of de novo malignancies and viral infections after kidney transplantation. We reported the results of switching Tacrolimus to Sirolimus in a kidney transplant recipient who suffered from severe cutaneous warts.

Published in American Journal of Internal Medicine (Volume 7, Issue 5)
DOI 10.11648/j.sr.20190705.11
Page(s) 60-63
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2019. Published by Science Publishing Group

Keywords

Kidney Transplantation, Human Papilloma Virus, Ano-Genital Neoplasms

References
[1] Veroux M, Corona D, Scalia G, Garozzo V, Gagliano M, Giuffrida G, et al. Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data. Transplant Proc. mai 2009; 41 (4): 1191-4.
[2] Arze S, Arze L, Abecia C. Post-transplantation Infections in Bolivia. Transplant Proc. mars 2016; 48 (2): 646-53.
[3] Alotaibi L, Provost N, Gagnon S, Franco EL, Coutlée F. Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. J Clin Virol Off Publ Pan Am Soc Clin Virol. juin 2006; 36 (2): 133-40.
[4] Skov Dalgaard L, Fassel U, Østergaard LJ, Jespersen B, SchmeltzSøgaard O, Jensen-Fangel S. Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis--an observational cohort study. BMC Nephrol. 8 juill 2013; 14: 137.
[5] Shahidi S, Moeinzadeh F, Mohammadi M, Gholamrezaei A. Sirolimus-based immunosuppression for treatment of cutaneous warts in kidney transplant recipients. Iran J Kidney Dis. sept 2011; 5 (5): 351-3.
[6] Bonatti H, Aigner F, De Clercq E, Boesmueller C, Widschwendner A, Larcher C, et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int Off J Eur Soc Organ Transplant. mars 2007; 20 (3): 238-46.
[7] Dharancy S, Catteau B, Mortier L, Boleslawski E, Declerck N, Canva V, et al. Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. déc 2006; 12 (12): 1883-7.
[8] Chin-Hong PV, Kwak EJ, AST Infectious Diseases Community of Practice. Human papillomavirus in solid organ transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. mars 2013; 13 Suppl 4: 189-200.
Cite This Article
  • APA Style

    Kmar Mnif, Soumaya Yaich, Fatma Fendri, Abdelrahmen Masmoudi, Khaled Charfeddine, et al. (2019). Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient. American Journal of Internal Medicine, 7(5), 60-63. https://doi.org/10.11648/j.sr.20190705.11

    Copy | Download

    ACS Style

    Kmar Mnif; Soumaya Yaich; Fatma Fendri; Abdelrahmen Masmoudi; Khaled Charfeddine, et al. Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient. Am. J. Intern. Med. 2019, 7(5), 60-63. doi: 10.11648/j.sr.20190705.11

    Copy | Download

    AMA Style

    Kmar Mnif, Soumaya Yaich, Fatma Fendri, Abdelrahmen Masmoudi, Khaled Charfeddine, et al. Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient. Am J Intern Med. 2019;7(5):60-63. doi: 10.11648/j.sr.20190705.11

    Copy | Download

  • @article{10.11648/j.sr.20190705.11,
      author = {Kmar Mnif and Soumaya Yaich and Fatma Fendri and Abdelrahmen Masmoudi and Khaled Charfeddine and Khawla Kammoun and Jamil Hachicha and Mohamed Ben Hmida},
      title = {Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient},
      journal = {American Journal of Internal Medicine},
      volume = {7},
      number = {5},
      pages = {60-63},
      doi = {10.11648/j.sr.20190705.11},
      url = {https://doi.org/10.11648/j.sr.20190705.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sr.20190705.11},
      abstract = {Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide and causes anal cancer. The incidence of HPV infections in renal transplant recipients is 17% to 45%. Using immunosuppression treatment has been associated with significantly lower risks of de novo malignancies and viral infections after kidney transplantation. We reported the results of switching Tacrolimus to Sirolimus in a kidney transplant recipient who suffered from severe cutaneous warts.},
     year = {2019}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient
    AU  - Kmar Mnif
    AU  - Soumaya Yaich
    AU  - Fatma Fendri
    AU  - Abdelrahmen Masmoudi
    AU  - Khaled Charfeddine
    AU  - Khawla Kammoun
    AU  - Jamil Hachicha
    AU  - Mohamed Ben Hmida
    Y1  - 2019/10/16
    PY  - 2019
    N1  - https://doi.org/10.11648/j.sr.20190705.11
    DO  - 10.11648/j.sr.20190705.11
    T2  - American Journal of Internal Medicine
    JF  - American Journal of Internal Medicine
    JO  - American Journal of Internal Medicine
    SP  - 60
    EP  - 63
    PB  - Science Publishing Group
    SN  - 2330-4324
    UR  - https://doi.org/10.11648/j.sr.20190705.11
    AB  - Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide and causes anal cancer. The incidence of HPV infections in renal transplant recipients is 17% to 45%. Using immunosuppression treatment has been associated with significantly lower risks of de novo malignancies and viral infections after kidney transplantation. We reported the results of switching Tacrolimus to Sirolimus in a kidney transplant recipient who suffered from severe cutaneous warts.
    VL  - 7
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Department of Dermatology, HediChaker Hospital, Sfax, Tunisia

  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Department of Nephrology, HediChaker Hospital, Sfax, Tunisia

  • Sections